Physician profile
Dalgis Durand
NPI 1760073175
$6,022.25
in general payments reported to CMS, 2019-2025
33 companies · $2,913 in 2025
The $2,913 reported for 2025 was more than what 97% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $56.63 · 2023: $1,464 · 2024: $1,589 · 2025: $2,913.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $5,668 · Education: $298.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $5,667.63 |
| Education | $297.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $869.84 | 2023-2025 | Erleada, Tecvayli, Imbruvica |
| Astrazeneca Pharmaceuticals LP | $824.17 | 2023-2025 | Imfinzi, Calquence, Tagrisso |
| Pfizer INC. | $622.39 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $502.19 | 2023-2025 | Keytruda, Lynparza, Welireg |
| Novartis Pharmaceuticals Corporation | $391.69 | 2023-2025 | Piqray, Kisqali |
| Takeda Pharmaceuticals U.S.A., INC. | $374.62 | 2022-2025 | Ninlaro, Iclusig, Alunbrig |
| Abbvie INC. | $346.70 | 2023-2025 | |
| Incyte Corporation | $234.36 | 2023-2024 | Jakafi |
| Alexion Pharmaceuticals, INC. | $210.93 | 2025 | Ultomiris |
| Glaxosmithkline, LLC. | $191.90 | 2023-2025 | Ojjaara, Zejula, Jemperli |
| Daiichi Sankyo INC. | $167.48 | 2025 | Datroway, Enhertu |
| Servier Pharmaceuticals LLC | $117.58 | 2023-2025 | |
| Stemline Therapeutics INC. | $108.62 | 2024-2025 | Orserdu |
| Lilly USA, LLC | $100.84 | 2023-2024 | Retevmo, Jaypirca, Verzenio |
| Eisai INC. | $90.72 | 2023-2025 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Emd Serono, INC. | $89.51 | 2024-2025 | |
| Pharmacosmos Therapeutics INC. | $89.35 | 2022-2025 | Monoferric |
| Celgene Corporation | $87.09 | 2023 | Pomalyst |
| Cumberland Pharmaceuticals, INC. | $75.25 | 2023 | Sancuso |
| Astellas Pharma US INC | $68.62 | 2023-2025 | Xtandi, Xospata |
| Bayer Healthcare Pharmaceuticals INC. | $53.56 | 2024 | |
| Sobi, INC | $44.40 | 2023 | |
| Array Biopharma INC | $44.24 | 2024-2025 | Mektovi, Braftovi, Xalkori |
| Amneal Pharmaceuticals LLC | $43.17 | 2023-2025 | Alymsys, Neulasta, Avastin |
| Myriad Genetic Laboratories, INC. | $39.68 | 2025 | Myrisk |
| Agios Pharmaceuticals, INC. | $39.65 | 2024 | |
| Geron Corporation | $35.34 | 2025 | Rytelo |
| Genzyme Corporation | $31.28 | 2024 | |
| Beone Medicines USA, INC. | $29.64 | 2025 | Brukinsa |
| Gilead Sciences, INC. | $29.46 | 2025 | |
| Jazz Pharmaceuticals INC. | $27.13 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $21.82 | 2025 | Lynozyfic |
| Seagen INC. | $19.03 | 2023 | Adcetris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dalgis Durand listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.